Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMAC: Cortisone vs Bone Marrow Aspirate for Shoulder OA
NCT03580148Phase 3
Key facts
- Status
- Completed
- Start
- Oct 2015
- Primary completion
- Jul 2020
- Countries
- 1
- Sponsor
- Women's College Hospital
- Modality
- Stem Cell Therapies
- Drugs
- bone marrow aspirate
- Conditions
- glenohumeral osteoarthritis
01
Overview
Phase 3, randomised, open-label trial of bone marrow aspirate in glenohumeral osteoarthritis, sponsored by Women's College Hospital. Primary endpoint: Western Ontario Osteoarthritis of the Shoulder Index at 12 months. Started Oct 2015; status: completed.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Adults 18-65 with primary glenohumeral osteoarthritis (Samilson and Prieto Stage 1-3) and no prior shoulder surgery or injections.
04
Endpoints
Primary
Western Ontario Osteoarthritis of the Shoulder Index
Beyond the preview
Go deeper on NCT03580148.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03580148.